A Comparison of the Transportability, and Its Role in Cytotoxicity, of Clofarabine, Cladribine, and Fludarabine by Recombinant Human Nucleoside Transporters Produced in Three Model Expression Systems-Reference-Cited by-同舟云学术

A Comparison of the Transportability, and Its Role in Cytotoxicity, of Clofarabine, Cladribine, and Fludarabine by Recombinant Human Nucleoside Transporters Produced in Three Model Expression Systems

Published:2005-10-18 Issue:1 Volume:69 Page:346-353
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

King Karen M.,Damaraju Vijaya L.,Vickers Mark F.,Yao Sylvia Y.,Lang Thach,Tackaberry Tracey E.,Mowles Delores A.,Ng Amy M. L.,Young James D.,Cass Carol E.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference44 articles.

1. Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes

2. Nucleoside transport in normal and neoplastic cells

3. THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS

4. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Transplant Immunology;2024-06

2. Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs;Current Protein & Peptide Science;2024-02

3. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development;Clinical Pharmacology & Therapeutics;2023-07-21

4. In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier;Drug Metabolism and Disposition;2023-05-31

5. Advancement in transporter-oriented nanoplatforms for cancer therapy;Journal of Drug Targeting;2023-04-05